Summary
Final FDA guidance clarifying which clinical decision support software functions are excluded from device regulation under the 21st Century Cures Act and which remain regulated device software, with examples across different CDS use cases.
Healthcare Implications
Directly shapes the regulatory treatment of clinical AI and decision-support tools used by providers, developers, and health systems by clarifying when software falls outside FDA device oversight and when it remains subject to medical device requirements.